quinolinic acid has been researched along with Cognition Disorders in 9 studies
Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim & Objective: To delineate the associations between executive impairments and changes in tryptophan catabolite (TRYCAT) patterning, negative symptoms and deficit schizophrenia." | 7.88 | The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling. ( Kanchanatawan, B; Maes, M, 2018) |
| "Aim & Objective: To delineate the associations between executive impairments and changes in tryptophan catabolite (TRYCAT) patterning, negative symptoms and deficit schizophrenia." | 3.88 | The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling. ( Kanchanatawan, B; Maes, M, 2018) |
| " Low xanthurenic acid occurred in both AD and with aging." | 3.85 | Kynurenine Pathway Metabolites in Alzheimer's Disease. ( Advani, R; Giil, LM; Midttun, Ø; Refsum, H; Smith, AD; Ueland, PM; Ulvik, A, 2017) |
| "These are astrocytosis, up-regulation of mRNA encoding the neuropeptide somatostatin (SRIF) and an increased expression of MHC Class II antigen." | 2.39 | Neuronal substrates for SIV encephalopathy. ( da Cunha, A; Eiden, LE; Rausch, DM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giil, LM | 1 |
| Midttun, Ø | 1 |
| Refsum, H | 1 |
| Ulvik, A | 1 |
| Advani, R | 1 |
| Smith, AD | 1 |
| Ueland, PM | 1 |
| Kanchanatawan, B | 1 |
| Maes, M | 1 |
| Croxson, PL | 1 |
| Walton, ME | 1 |
| Boorman, ED | 1 |
| Rushworth, MF | 1 |
| Bannerman, DM | 1 |
| Kandanearatchi, A | 1 |
| Brew, BJ | 1 |
| Schwarz, MJ | 1 |
| Guillemin, GJ | 1 |
| Teipel, SJ | 1 |
| Buerger, K | 1 |
| Hampel, H | 1 |
| da Cunha, A | 1 |
| Eiden, LE | 2 |
| Rausch, DM | 2 |
| Heyes, MP | 1 |
| Murray, EA | 1 |
| Lendvay, J | 1 |
| Sharer, LR | 1 |
| Ward, JM | 1 |
| Rehm, S | 1 |
| Nohr, D | 1 |
| Weihe, E | 1 |
| O'Neill, AB | 1 |
| Morgan, SJ | 1 |
| Brioni, JD | 1 |
| Schuster, GM | 1 |
| Schmidt, WJ | 1 |
2 reviews available for quinolinic acid and Cognition Disorders
| Article | Year |
|---|---|
The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.
Topics: Central Nervous System Diseases; Cognition Disorders; HIV; HIV Infections; Humans; Kynurenine; Quino | 2012 |
Neuronal substrates for SIV encephalopathy.
Topics: Animals; Astrocytes; Cognition Disorders; Disease Progression; Encephalitis, Viral; Gene Expression | 1994 |
7 other studies available for quinolinic acid and Cognition Disorders
| Article | Year |
|---|---|
Kynurenine Pathway Metabolites in Alzheimer's Disease.
Topics: 3-Hydroxyanthranilic Acid; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cognition Disorders; C | 2017 |
The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Cognition Disorders; Executive Function; Female; Huma | 2018 |
Unilateral medial frontal cortex lesions cause a cognitive decision-making deficit in rats.
Topics: Animals; Cognition Disorders; Decision Making; Dopamine; Frontal Lobe; Functional Laterality; Male; | 2014 |
Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls.
Topics: Aged; Alzheimer Disease; Biomarkers; Blood-Brain Barrier; Brain Chemistry; Chromatography, High Pres | 2013 |
Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys.
Topics: Animals; Brain; Cerebral Cortex; Cognition; Cognition Disorders; Glial Fibrillary Acidic Protein; Ma | 1994 |
Histological and behavioral protection by (-)-nicotine against quinolinic acid-induced neurodegeneration in the hippocampus.
Topics: Animals; Brain Diseases; Cognition Disorders; Hippocampus; Male; Maze Learning; Memory Disorders; Ne | 1998 |
D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task.
Topics: Analysis of Variance; Animals; Cognition Disorders; Cycloserine; Hippocampus; Male; Memory Disorders | 1992 |